{
 "awd_id": "0419287",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase I:  Development of Anticancer Drugs Using Novel Drug Delivery Systems",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Om P. Sahai",
 "awd_eff_date": "2004-07-01",
 "awd_exp_date": "2004-12-31",
 "tot_intn_awd_amt": 100000.0,
 "awd_amount": 100000.0,
 "awd_min_amd_letter_date": "2004-06-04",
 "awd_max_amd_letter_date": "2004-06-04",
 "awd_abstract_narration": "This Small Business Innovation Research (SBIR) Phase I project is to develop a novel delivery vehicle for anti-cancer drugs using guanidine-modified molecule-based systems.\r\n\r\nThe commercial application of this project will be in the area of anti-cancer therapies.  This drug delivery system may enable or improve the performance of known pharmaceuticals by modulating their administration regimen or intake routes.  It may also help salvage many clinically proven therapeutics that were abandoned due to their low cellular uptakes and / or poor solubility and bioavailability.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "CJ",
   "pi_last_name": "Yu",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "CJ Yu",
   "pi_email_addr": "yucjyu@gmail.com",
   "nsf_id": "000337706",
   "pi_start_date": "2004-06-04",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "GlyPort, Inc.",
  "inst_street_address": "118 S. Berkeley Ave.",
  "inst_street_address_2": "",
  "inst_city_name": "Pasadena",
  "inst_state_code": "CA",
  "inst_state_name": "California",
  "inst_phone_num": "6268447896",
  "inst_zip_code": "911074052",
  "inst_country_name": "United States",
  "cong_dist_code": "28",
  "st_cong_dist_code": "CA28",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": "E4NESFWLTZU7"
 },
 "perf_inst": {
  "perf_inst_name": "GlyPort, Inc.",
  "perf_str_addr": "118 S. Berkeley Ave.",
  "perf_city_name": "Pasadena",
  "perf_st_code": "CA",
  "perf_st_name": "California",
  "perf_zip_code": "911074052",
  "perf_ctry_code": "US",
  "perf_cong_dist": "28",
  "perf_st_cong_dist": "CA28",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "9181",
   "pgm_ref_txt": "BIOPROCESSING/BIOMOLECULAR MATERIALS"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0104",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0104",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2004,
   "fund_oblg_amt": 100000.0
  }
 ],
 "por": null
}